The objective of this study was to assess the value of a urine bacterial culture performed before prostate biopsy. We performed a prospective study on 353 patients who underwent prostate biopsy. All patients had a urine bacterial culture performed before biopsy. We compared the outcomes of patients with bacteriuria (left untreated) with those of patients without bacteriuria. Of the 353 men, 12 had a pre-biopsy-positive bacterial culture and underwent prostate biopsy without any infectious complication. Fifteen patients with a negative pre-biopsy culture developed a postbiopsy-positive bacterial culture, but remained asymptomatic without any treatment. Only four men from the group without pre-biopsy bacteriuria developed an infectious complication, requiring 3 weeks of antibiotic therapy. The complication rates were similar for both groups. Our results suggest that routine urine bacterial culture before prostate biopsy is not useful when antibiotic prophylaxis and enema are performed. We do, however, suggest performing a urine bacterial culture before prostate biopsy for patients with a previous history of urinary tract infections.
Introduction
Transrectal needle biopsy procedure is one of the most common procedures performed by urologists. Although it is considered to be safe, post-biopsy sepsis is commonly seen in practice. Infection reports vary across studies, and even if it is considered to be consensual, the use of antibiotic prophylaxis varies between institutions. In the literature, bacteriuria is seen in 20-53% 1 and prostatitis in 0.6-4% 2 of the transrectal prostate biopsies. Urine bacterial culture before prostate biopsy has been performed by many institutions without proof of real benefit. 1 As the bacteria are apparently introduced into the urine and/or blood from the rectum, we found that the routine urine culture is unnecessary before prostate biopsy. In our institution, the prostatitis rate after prostate biopsy is between 1 and 3% and is similar to the rates reported in the literature. We performed a prospective study to assess the value of urine bacterial culture performed before prostate biopsy.
Materials and methods
This study was conducted between 2002 and 2006 at our outpatient clinic and included data collected from 380 consecutive men. All men who underwent prostate biopsy in this time period were enrolled in the study.
All subjects underwent urine bacterial culture 48-72 h before prostatic biopsy with prospective analyses of temperature and infectious events. Inclusion criteria for the study were any indications for prostatic biopsy (PSA 44 or abnormal digital rectal examination). All patients signed an informed consent before inclusion. The exclusion criteria were any previous anal or rectal surgery, current antibiotic or anti-inflammatory treatment, immunosuppressive therapy, previous acute or chronic prostatitis or any symptoms evocating prostatitis. Patients receiving antiplatelet agents or anti-vitamin K treatment were asked to stop and substitute lowmolecular-weight heparin (Lovenox, Sanofi-Aventis, Paris, France) for their current treatment. Five urologists performed the biopsies using the same protocol.
After an enema (Normacol, Norgine Pharma, Middlesex, UK) performed on the morning of the biopsy, each patient underwent a transrectal ultrasound-guided prostate biopsy with an 18-G Trucut needle (Bioty-cut, Bard, Covington, GA, USA). Median number of cores performed per patient was 10. All patients received 200 mg of ofloxacin at 2-6 h before biopsy. After an informed consent, patients were instructed to follow-up 15 days after the biopsy. They were also asked to record their temperature at 1, 12, 24 h, and 7 days after the biopsy, and more frequently if fever appeared. All patients were given an emergency telephone number. Urine cultures were obtained from all patients 48 h after biopsy. Positive urine cultures were defined as one type of bacteria for 410 000 colony-forming units per ml.
Complications were recorded prospectively (hematuria, rectal bleeding and fever (temperature 438 1C)). On completion of patient enrollment, data were available for 353 patients.
Statistical analyses were performed using Excel software (Microsoft, Redmond, WA, USA). Significance was set at Po0.05. Continuous variables were compared using analysis of variance, whereas comparisons of nominal variables were performed using Fisher's exact test and w 2 analysis.
Results

Incidence of infectious complications
Demographic and infectious characteristics are summarized in Tables 1 and 2 . There were no differences between groups. The incidence of post-biopsy septicemia was 1.1% (defined as fever and irritative urinary symptoms), and none of these patients had pre-biopsy bacteriuria (P ¼ 0.4). For men with post-biopsy septicemia, all bacterial cultures were positive for Escherichia coli and were found to be sensitive to all quinolones and b-lactamines. All men became asymptomatic in o2 days after the beginning of the association of ceftrixone and gentamycin. A 3-week course of ceftriaxone was prescribed after the patient's discharge. All patients attended an 8-week follow-up appointment and remained asymptomatic with sterile urinary bacterial cultures. No demographic or risk factor-related criterion (number of cores, diabetes) was found in patients with post-biopsy septicemia. None of them developed a chronic pelvic pain syndrome.
Correlation with pre-biopsy urine analysis
In total, 12 of the 353 men had a positive pre-biopsy culture and underwent a prostate biopsy without any treatment. None had fever or complications following the procedure. Fifteen other men who had a negative pre-biopsy culture had a positive culture following the procedure (all more than 10 3 per ml: three E. coli, seven Streptococcus, five Staphylococcus). None of these men were treated as they remained asymptomatic.
There was no difference in the complication rates within groups (Table 3 ). The rate of rectal bleeding during biopsy was 22-25%. Rectal bleeding occurred in 12-18.6% of biopsies (without any other symptom, such as fever) but these patients did not require hospitalization or transfusion. All complications resolved in p3 days.
Discussion
Our study suggests that routine urine bacterial cultures before prostatic biopsy is not necessary as we found no difference in the complication rates between the groups for whom culture results were positive and for whom they were negative. The low bacteriuria rate is notable and likely linked to our department's use of prophylactic antibiotics and an enema before prostate biopsy.
Our study is the first to assess the value of a urine bacterial culture before prostate biopsy. The small number of patients with bacteriuria is a limitation; however, no trend toward group differences was observed. The number of patients involved in the study is insufficient to capture the rarer complication of septicemia. Moreover, we have performed prostate biopsies in this way for many years with no more frequent complications than other departments that perform routine pre-biopsy urine bacterial cultures. Within our study, the fever rate was 0.4%. This rate is lower than that observed in the European screening study, which analyzed data from 5676 prostate biopsies. 2 This study reported a 3.5% fever rate, but antibiotic prophylaxis was provided (trimethoprim-sulfamethoxazole or ciprofloxacin) only if the patient had diabetes or a previous history of urinary tract infections. This choice of antibiotic prophylaxis seems to be less effective than that of ofloxacin, which was used in our study. The efficacy of different antibiotics for prophylaxis has been examined. Quinolones are initially effective against most Gramnegative and Gram-positive bacteria and reach effective concentrations in the prostate and urine. 3 We opted for ofloxacin based on the results of previous studies. 4, 5 There is a rich literature regarding antibiotic prophylaxis and many different treatments and durations have been assessed. The use of routine antibiotic prophylaxis Urine culture before prostate biopsy F Bruyère et al is now acceptable and has been shown to decrease the rate of infection following prostatic biopsy. The kinetic characteristics of an antibiotic should aid in the selection of the optimal treatment. The medication should achieve peak tissue concentration during the procedure, which is why the antibiotic should be administered 1-2 h before prostatic biopsy. 5 However, one study demonstrated that antibiotics can be administered during the biopsy without an increased incidence of complications. 6 The authors of that study claim that it improved the rate of successful treatments. In their study, eleven patients (out of 1322) had bacteriuria before the procedure, three of whom developed asymptomatic infections (27%). This high rate was explained by the absence of a rectal enema. In addition, it can be noted that one patient had a previous infection that was treated with quinolones, explaining the resistance to the prophylactic antibiotics. Thus, it is important to know whether the patient has been recently treated with antibiotics so that optimal antibiotic prophylaxis can be given. In our study, none of the patients with post-biopsy prostatitis had a positive preoperative bacterial culture. All these elements argue against the usefulness of routine urine bacterial cultures before prostatic biopsy.
Noninfectious complications of prostate biopsy have also been examined. In our study, the rates of hematuria and rectal bleeding after biopsy were 33 and 9.9%, respectively. These rates are similar to those reported in previous studies: 22-50% for hematuria and 1-22% for rectal bleeding. 6, 7 We believe that the routine use of a urine bacterial culture before prostatic biopsy will increase the number of antibiotics prescribed, a factor directly related to the increased resistance rates of bacteria. 8, 9 However, if a physician does elect to perform a urine bacterial culture and it is positive, the urologist may elect to perform the prostate biopsy with the patient taking antibiotics rather than delaying the procedure.
The cost of a routine bacterial culture was calculated by Lindstedt et al. 10 as 8000 euros per 1000 cultures. This cost would likely increase if cultures were performed more routinely, especially given the increasing number of prostate biopsies performed each year.
Even though none of the culture-positive patients in our study were given extra antibiotic prophylaxis, we believe that performing routine urine bacterial cultures before prostate biopsy will increase the number of antibiotics prescribed, ultimately increasing bacterial resistance and overall health-care costs. In patients with antibiotic resistance who develop post-biopsy sepsis, hospitalization may result and may last as long as 13 days. 11 On the other hand, a past history of urinary tract infections, prostatitis and urinary retention are important variables to consider and could be an indication for a pre-biopsy bacterial culture. 2 We propose that not performing routine urinary bacterial cultures will help to reduce the total cost of a prostate biopsy and decrease rates of antibiotic resistance. Antibiotic resistance is a problem that is estimated to cost almost 5 billion euros per year. 9 Reducing the use of routine urinary bacterial analyses would likely decrease the total cost of care to a greater degree than the initial cost of the urine analysis.
Conclusions
Our results suggest that performing routinely a urinary bacterial culture before prostatic biopsy offers no added prognostic value for post-biopsy infection. Further studies need to be conducted to determine how best to reduce the rate of infection without increasing the cost of a prostate biopsy, a procedure that is becoming increasingly common.
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